Autres langues Scinai Immunotherapeutics Ltd.

Actions

SCNI

US09073Q2049

Marché Fermé - Nasdaq Autres places de cotation 22:30:01 03/05/2024			Varia. 5j.	Varia. 1 janv.
0,4661 ^USD	+1,21 %		+3,58 %	-21,72 %

08/04	Les fonds négociés en bourse et les contrats à terme sur actions gagnent légèrement avant la cloche du lundi, alors que la probabilité d'une baisse des taux d'intérêt en juin diminue	MT
08/04	Ayana Pharma choisit l'unité CDMO de Scinai Immunotherapeutics pour fournir des services de développement de médicaments et de fabrication cGMP	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Scinai Immunotherapeutics CDMO Unit Selected by Ayana Pharma to Provide Drug Development and cGMP Manufacturing Services	09/04
Exchange-Traded Funds, Equity Futures Gain Slightly Pre-Bell Monday as June Rate Cut Likelihood Falls	08/04
Scinai Immunotherapeutics' CDMO Unit Selected by Ayana Pharma to Provide Drug Development and cGMP Manufacturing Services	08/04
Ayana Pharma Selects Scinai Immunotherapeutics' CDMO Unit to Provide Drug Development and cGMP Manufacturing Services	08/04
Scinai leadership to attend BIO-Europe Spring 2024	12/03
Scinai Immunotherapeutics to showcase its cGMP biologics CDMO and innovative NanoAb pipeline at MIXiii 2024	01/03
Scinai to showcase its cGMP biologics CDMO and innovative NanoAb pipeline at MIXiii 2024	29/02
Scinai Welcomes Liat Halpert as Head of Business Development and Sales	13/02
Scinai Immunotherapeutics Ltd. Appoints Liat Halpert as Head of Business Development and Sales	13/02
Scinai Immunotherapeutics Congratulates its Co-Lead Scientific Research Collaborator Dirk Gorlich on Louis-Jeantet Prize	26/01
Scinai Immunotherapeutics Ltd. announced that it has received $1.694259 million in funding	12/01
Scinai Immunotherapeutics CEO Issues Letter to Shareholders	04/01
Scinai Immunotherapeutics Exercises Outstanding Warrants for $1.69 Million in Proceeds	29/12
Scinai Immunotherapeutics Ltd. announced that it expects to receive $1.694259 million in funding	29/12
Scinai (NASDAQ: SCNI) to Host Analyst and Investor Webinar on January 9	27/12
Scinai Announces Promising Results in a Psoriatic Human Skin Model	12/12
Study published in Antiviral Research supports promise of Scinai Immunotherapeutics coronavirus NanoAb as aerosolized prophylactic and therapeutic drug	12/12
Study published in Antiviral Research supports promise of Scinai Immunotherapeutics' coronavirus NanoAb as aerosolized prophylactic and therapeutic drug	11/12
European Investment Bank extends maturity of its finance facility with Scinai Immunotherapeutics from 2027 to 2031	30/11
European Investment Bank (EIB) extends maturity of its finance facility with Scinai Immunotherapeutics from 2027 to 2031	29/11

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Scinai Immunotherapeutics Ltd.

Actions

SCNI

US09073Q2049

Autres langues

Filtres